Latest Cancer News

The Novel Small Molecule Pictilisib May Benefit Women with Advanced Breast Cancer (03-5-2015)
The addition of the investigational drug pictilisib to Faslodex® (fulvestrant) has been demonstrated to delay the time of cancer in women with advanced or metastatic breast cancer to be positive for both... Continue Reading

Palbociclib/Letrozole Improves Outcomes of Estrogen Receptor–Positive/HER2-Negative Advanced Breast Cancer (02-27-2015)
The results of the phase II PALOMA-1/TRIO-18 trial were recently reported in The Lancet Oncology and suggest that the addition of Ibrance® (palbociclib) to Femara® (letrozole) delayed the time to cancer... Continue Reading

FDA Grants Breakthrough Therapy Designation for MPDL3280A, an anti-PDL1 Investigational Cancer Immunotherapy for Non-Small Cell Lung Cancer (02-26-2015)
The investigational cancer immunotherapy MPDL3280A (anti-PDL1) has received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA). The designation was granted for the treatment... Continue Reading

More Cancer News

Locations

 
Jackson
322 Hospital Boulevard
Jackson, TN 38305
731-668-1668
800-870-5471
 
 
Dyersburg
440 Wilkinson Drive
Dyersburg, TN 38024
731 285-2211
888-748-8511
 
 
Paris
1290 Kelley Drive
Paris, TN 38242
731-644-3522
800-221-0948
 
 
Union City
1209 Reelfoot Ave.
Union City, TN 38261
731-884-8611
888-941-8611